UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Gene activation of CEBPA using saRNA: preclinical studies of the first in human saRNA drug candidate for liver cancer

Oncogene, 2018-06, Vol.37 (24), p.3216-3228

2018

Volltextzugriff (PDF)

Developing small activating RNA as a therapeutic: current challenges and promises

Therapeutic delivery, 2019-03, Vol.10 (3), p.151-164

2019

Volltextzugriff (PDF)

Non-alcoholic Fatty Liver Disease: a sign of systemic disease

Metabolism, clinical and experimental, 2017-07, Vol.72, p.94-108

2017

Volltextzugriff (PDF)

MicroRNAs targeting oncogenes are down-regulated in pancreatic malignant transformation from benign tumors

PloS one, 2012-02, Vol.7 (2), p.e32068

2012

Volltextzugriff (PDF)

Will Nanotechnology Bring New Hope for Gene Delivery?

Trends in biotechnology (Regular ed.), 2017-05, Vol.35 (5), p.434-451

2017

Volltextzugriff (PDF)

The Effect of Interleukin-10 Immunotherapy on Renal Ischemia-Reperfusion Injury: A Systematic Review and Meta-Analysis of Preclinical Studies

International journal of molecular sciences, 2024-06, Vol.25 (11), p.6231

2024

Volltextzugriff (PDF)

C/EBPα Short-Activating RNA Suppresses Metastasis of Hepatocellular Carcinoma through Inhibiting EGFR/β-Catenin Signaling Mediated EMT

PloS one, 2016-04, Vol.11 (4), p.e0153117-e0153117

2016

Volltextzugriff (PDF)

PRIME-HCC: phase Ib study of neoadjuvant ipilimumab and nivolumab prior to liver resection for hepatocellular carcinoma

BMC cancer, 2021-03, Vol.21 (1), p.301-301, Article 301

2021

Volltextzugriff (PDF)

Cannabinoids in the landscape of cancer

Journal of cancer research and clinical oncology, 2021-09, Vol.147 (9), p.2507-2534

2021

Volltextzugriff (PDF)

Mechanisms involved in the activation of C/EBPα by small activating RNA in hepatocellular carcinoma

Oncogene, 2019-05, Vol.38 (18), p.3446-3457

2019

Volltextzugriff (PDF)

Development and Mechanism of Small Activating RNA Targeting CEBPA, a Novel Therapeutic in Clinical Trials for Liver Cancer

Molecular therapy, 2017-12, Vol.25 (12), p.2705-2714

2017

Volltextzugriff (PDF)

RNA Activation-A Novel Approach to Therapeutically Upregulate Gene Transcription

Molecules (Basel, Switzerland), 2021-10, Vol.26 (21), p.6530

2021

Volltextzugriff (PDF)

Analysis of Endoscopic Radiofrequency Ablation of Biliary Malignant Strictures in Pancreatic Cancer Suggests Potential Survival Benefit

Digestive diseases and sciences, 2015-11, Vol.60 (11), p.3449-3455

2015

Volltextzugriff (PDF)

An RNA Aptamer Targeting the Receptor Tyrosine Kinase PDGFRα Induces Anti-tumor Effects through STAT3 and p53 in Glioblastoma

Molecular therapy. Nucleic acids, 2019-03, Vol.14, p.131-141

2019

Volltextzugriff (PDF)

Upregulation of C/EBPα Inhibits Suppressive Activity of Myeloid Cells and Potentiates Antitumor Response in Mice and Patients with Cancer

Clinical cancer research, 2021-11, Vol.27 (21), p.5961-5978

2021

Volltextzugriff (PDF)

Blind SELEX Approach Identifies RNA Aptamers That Regulate EMT and Inhibit Metastasis

Molecular cancer research, 2017-07, Vol.15 (7), p.811-820

2017

Volltextzugriff (PDF)

MTL-CEBPA Combined with Immunotherapy or RFA Enhances Immunological Anti-Tumor Response in Preclinical Models

International journal of molecular sciences, 2021-09, Vol.22 (17), p.9168

2021

Volltextzugriff (PDF)

Intra‐Arterial Immunoselected CD34+ Stem Cells for Acute Ischemic Stroke

Stem cells translational medicine, 2014-11, Vol.3 (11), p.1322-1330

2014

Volltextzugriff (PDF)

MicroRNAs Cooperatively Inhibit a Network of Tumor Suppressor Genes to Promote Pancreatic Tumor Growth and Progression

Gastroenterology (New York, N.Y. 1943), 2014, Vol.146 (1), p.268-277.e18

2014

Volltextzugriff (PDF)

Glypican-1 is enriched in circulating-exosomes in pancreatic cancer and correlates with tumor burden

Oncotarget, 2018-04, Vol.9 (27), p.19006-19013

2018

Volltextzugriff (PDF)

The use of radiofrequency ablation in pancreatic cancer in the midst of the dawn of immuno-oncology

Medical oncology (Northwood, London, England), 2018-12, Vol.35 (12), p.151-3, Article 151

2018

Volltextzugriff (PDF)

Endogenous aldehyde accumulation generates genotoxicity and exhaled biomarkers in esophageal adenocarcinoma

Nature communications, 2021-03, Vol.12 (1), p.1454-12, Article 1454

2021

Volltextzugriff (PDF)

microRNAs with prognostic significance in pancreatic ductal adenocarcinoma: A meta-analysis

European journal of cancer (1990), 2015-07, Vol.51 (11), p.1389-1404

2015

Volltextzugriff (PDF)

Development of MTL-CEBPA: Small Activating RNA Drug for Hepatocellular Carcinoma

Current pharmaceutical biotechnology, 2018-01, Vol.19 (8), p.611-621

2018

Volltextzugriff (PDF)

Anti-tumour activity of a first-in-class agent NUC-1031 in patients with advanced cancer: results of a phase I study

British journal of cancer, 2018-10, Vol.119 (7), p.815-822

2018

Volltextzugriff (PDF)

1 – 25 von 417

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(333)
Mit Volltextzugriff
(357)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Gene activation of CEBPA using saRNA: preclinical studies of the first in human saRNA drug candidate for liver cancer

Developing small activating RNA as a therapeutic: current challenges and promises

Non-alcoholic Fatty Liver Disease: a sign of systemic disease

MicroRNAs targeting oncogenes are down-regulated in pancreatic malignant transformation from benign tumors

Will Nanotechnology Bring New Hope for Gene Delivery?

The Effect of Interleukin-10 Immunotherapy on Renal Ischemia-Reperfusion Injury: A Systematic Review and Meta-Analysis of Preclinical Studies

C/EBPα Short-Activating RNA Suppresses Metastasis of Hepatocellular Carcinoma through Inhibiting EGFR/β-Catenin Signaling Mediated EMT

PRIME-HCC: phase Ib study of neoadjuvant ipilimumab and nivolumab prior to liver resection for hepatocellular carcinoma

Cannabinoids in the landscape of cancer

Mechanisms involved in the activation of C/EBPα by small activating RNA in hepatocellular carcinoma

Development and Mechanism of Small Activating RNA Targeting CEBPA, a Novel Therapeutic in Clinical Trials for Liver Cancer

RNA Activation-A Novel Approach to Therapeutically Upregulate Gene Transcription

Analysis of Endoscopic Radiofrequency Ablation of Biliary Malignant Strictures in Pancreatic Cancer Suggests Potential Survival Benefit

An RNA Aptamer Targeting the Receptor Tyrosine Kinase PDGFRα Induces Anti-tumor Effects through STAT3 and p53 in Glioblastoma

Upregulation of C/EBPα Inhibits Suppressive Activity of Myeloid Cells and Potentiates Antitumor Response in Mice and Patients with Cancer

Blind SELEX Approach Identifies RNA Aptamers That Regulate EMT and Inhibit Metastasis

MTL-CEBPA Combined with Immunotherapy or RFA Enhances Immunological Anti-Tumor Response in Preclinical Models

Intra‐Arterial Immunoselected CD34+ Stem Cells for Acute Ischemic Stroke

MicroRNAs Cooperatively Inhibit a Network of Tumor Suppressor Genes to Promote Pancreatic Tumor Growth and Progression

Glypican-1 is enriched in circulating-exosomes in pancreatic cancer and correlates with tumor burden

The use of radiofrequency ablation in pancreatic cancer in the midst of the dawn of immuno-oncology

Endogenous aldehyde accumulation generates genotoxicity and exhaled biomarkers in esophageal adenocarcinoma

microRNAs with prognostic significance in pancreatic ductal adenocarcinoma: A meta-analysis

Development of MTL-CEBPA: Small Activating RNA Drug for Hepatocellular Carcinoma

Anti-tumour activity of a first-in-class agent NUC-1031 in patients with advanced cancer: results of a phase I study

Suchergebnisse filtern